CONFIRMED TO ATTEND
Why TPD & Induced Proximity Pharma Partnering Summit?
The TPD & Induced Proximity Pharma Partnering Summit is the premier business development forum for companies developing protein degradation TACs & Glues, and induced proximity-led protein enhancement, stabilization, or inhibition.
This exclusive summit brings together over 80 on-scope and in-strategy companies, providing unparalleled networking opportunities to connect with key decision-makers from leading pharma companies.
Designed to maximize your success, the scientifically focused environment of the summit guarantees a minimum of 25% meeting acceptance rates and at least four productive meetings with strong follow-up potential. Increase your meeting success rates and build meaningful collaborations in this exclusive setting.
Key Figures from Partnering Series
meetings through the partnering portal
acceptance rate of meetings, versus 11% industry standard
total attendees, including: 20+ pharma, 65+ biotech
companies
director level and above
Size of Networking Opportunity
Total Audience Networking
Creating Alignment Through Targeted Critical Mass:
Exclusive to the targeted protein degradation and induced proximity pharma, biotech, and investor community, you are guaranteed a greater number of strategically matched interactions when networking candidly. Free from CROs/CDMOs or other service providers, maximize speaking with the highest priority contacts for your company while they and you are free from conflicting priorities.
Interested Group Matchmaking
Group Matchmaking
Tell us which pharma you want to meet in advance, and we will coordinate face-to-face, sit-down meetings with them during protected networking time at the pharma matchmaking tables on day one.
Individual Meetings: One-on-One Partneringâ„¢
The industry's favorite partnering portal, search the full attendee list, message and pre-schedule meetings in calendars ahead of the conference, and automatically book private meeting spaces: the most efficient way to set yourself up for success.
EXPERT SPEAKERS INCLUDE

Adam Gilbert
Executive Director, External Innovation Accelerator
Pfizer

Elena Diez
Senior Director External Innovation
JanssenÂ

Yue Xiong
Chief Scientific Officer
Cullgen

Randolph Lopez
Chief Technology Officer & Co-Founder
A-Alpha Bio

Steve Bellon
Chief Scientific Officer
Foghorn Therapeutics